Skip to main content
February 5, 2021

Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya

Nyabuti MN Petersen ML Bukusi EA Kamya MR Mwangwa F Kabami J Sang N Charlebois ED Balzer LB Schwab JD Camlin CS Black D Clark TD Chamie G Havlir DV Ayieko J. Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya. February 2021. PLOS One, 16(2):e0243167.
January 13, 2021

Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial

Dragoman MV Grossman D Nguyen MH Habib N Kapp N Tamang A Bessenaar T Duong LD Gautam J Yoko JL Hong M Gulmezoglu M. Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial. January 2021. Contraception, 103(3):163-170.